Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 1, 2017MedicineOpen Access

Ki-67 labeling index is a predictive marker for a pathological complete response to neoadjuvant chemotherapy in breast cancer

View Full Paper
Ask AI
Bookmark
Share

Authors

MTMiaomiao TaoSCShu ChenXZXianquan Zhang

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Tao et al. (2017) studied this question.

synapsesocial.com/papers/6a08e0b83589fa5d64d60201https://doi.org/10.1097/md.0000000000009384
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Stability of the HER2 gene after primary chemotherapy in advanced breast cancer2005 · 49 citations
  2. 2New Guidelines to Evaluate the Response to Treatment in Solid Tumors2000 · 15,762 citations
  3. 3High Proliferation Predicts Pathological Complete Response to Neoadjuvant Chemotherapy in Early Breast Cancer2016 · 58 citations
  4. 4Effect of preoperative chemotherapy on the outcome of women with operable breast cancer.1998 · 2,205 citations
  5. 5Neoadjuvant chemotherapy in triple‐negative breast cancer: A multicentric retrospective observational study in real‐life setting2017 · 52 citations